| Autor: |
Chilimuri, Sridhar, Mantri, Nikhitha, Gurjar, Hitesh, Youthjug, Karnokjun Annie, Sun, Haozhe, Gongati, Sudharsan, Zahid, Maleeha, Ronderos, Diana Maria, De La Cruz, Angel, Varanasi, Paavana, Shin, Dongmin, Nayudu, Suresh Kumar |
| Zdroj: |
Journal of the National Medical Association; 20210101, Issue: Preprints |
| Abstrakt: |
Monoclonal antibody therapy (MAT) is recommended in mild to moderate Coronavirus disease 2019 (COVID-19) patients who are at risk of progressing to severe disease. Due to limited data on its outcomes and the logistic challenges in administering the drug, MAT has not been widely used in the United States (US) despite of emergency use authorization (EUA) approval by the Food and Drug Administration (FDA). |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
